LENSAR, Inc.
LNSRNASDAQHealthcare● Active
$5.60
+$0.00(+0.00%)
Market Cap$67784237
P/E Ratio—
52W High$13.67
52W Low$5.06
LENSAR, Inc. (LNSR) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
LNSR · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 8, 2026EPS Actual
$1.56
Est. $0.18 · +743.2%
Revenue
$0.01B
Est. $0.01B · -6.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 8, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue✓ 1-Quarter EPS Beat Streak
LNSR reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | -$0.17 | — | — | — | $0.01B | — |
| ▲ Q2 FY2026 | May 8, 2026 | $0.18 | $1.56 | +743.2% | $0.01B | $0.01B | -6.0% |
| ▼ Q1 FY2026 | Mar 31, 2026 | -$0.07 | -$0.12 | -80.7% | $0.01B | $0.02B | -37.6% |
| ▼ Q4 FY2025 | Nov 6, 2025 | -$0.10 | -$0.31 | -210.0% | $0.01B | $0.02B | -29.5% |
| ▼ Q3 FY2025 | Aug 7, 2025 | -$0.08 | -$0.15 | -87.5% | $0.01B | $0.02B | -21.5% |
| ▼ Q2 FY2025 | May 8, 2025 | -$0.15 | -$2.32 | -1446.7% | $0.01B | $0.01B | +5.7% |
| ▼ Q1 FY2025 | Feb 27, 2025 | -$0.18 | -$1.61 | -794.4% | $0.02B | $0.01B | +19.5% |
| ▲ Q4 FY2024 | Nov 7, 2024 | -$0.29 | -$0.13 | +55.2% | $0.01B | $0.01B | -9.4% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
-$0.17
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 8, 2026Beat
EPS Actual
$1.56
EPS Est.
$0.18
EPS Surpr.
+743.2%
Revenue
$0.01B
Q1 FY2026
Mar 31, 2026Miss
EPS Actual
-$0.12
EPS Est.
-$0.07
EPS Surpr.
-80.7%
Revenue
$0.01B
Q4 FY2025
Nov 6, 2025Miss
EPS Actual
-$0.31
EPS Est.
-$0.10
EPS Surpr.
-210.0%
Revenue
$0.01B
Q3 FY2025
Aug 7, 2025Miss
EPS Actual
-$0.15
EPS Est.
-$0.08
EPS Surpr.
-87.5%
Revenue
$0.01B
Q2 FY2025
May 8, 2025Miss
EPS Actual
-$2.32
EPS Est.
-$0.15
EPS Surpr.
-1446.7%
Revenue
$0.01B
Q1 FY2025
Feb 27, 2025Miss
EPS Actual
-$1.61
EPS Est.
-$0.18
EPS Surpr.
-794.4%
Revenue
$0.02B
Q4 FY2024
Nov 7, 2024Beat
EPS Actual
-$0.13
EPS Est.
-$0.29
EPS Surpr.
+55.2%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.15 | $0.16 | $0.17 | 1 |
| Q3 FY2028 | $0.16 | $0.17 | $0.18 | 1 |
| Q2 FY2028 | $0.11 | $0.11 | $0.11 | 1 |
| Q1 FY2028 | $0.11 | $0.11 | $0.11 | 1 |
| Q4 FY2027 | $0.03 | $0.03 | $0.03 | 1 |
| Q3 FY2027 | $0.03 | $0.03 | $0.03 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 8, 2026 | +743.2% | $5.23 | $5.64 | +7.84% |
| ▼ Q1 FY2026 | Mar 31, 2026 | -80.7% | $5.87 | $5.96 | +1.53% |
| ▼ Q4 FY2025 | Nov 6, 2025 | -210.0% | $12.52 | $11.44 | -8.63% |
| ▼ Q3 FY2025 | Aug 7, 2025 | -87.5% | $13.03 | $12.84 | -1.46% |
| ▼ Q2 FY2025 | May 8, 2025 | -1446.7% | $13.83 | $13.81 | -0.14% |
| ▼ Q1 FY2025 | Feb 27, 2025 | -794.4% | $9.47 | $10.87 | +14.78% |
| ▲ Q4 FY2024 | Nov 7, 2024 | +55.2% | $5.86 | $6.87 | +17.24% |
| ▼ Q3 FY2024 | Aug 8, 2024 | -82.8% | $4.43 | $3.99 | -9.93% |
Q2 FY2026+7.84%
Report Date
May 8, 2026
EPS Beat/Miss
+743.2%
Price Before
$5.23
Price After
$5.64
Q1 FY2026+1.53%
Report Date
Mar 31, 2026
EPS Beat/Miss
-80.7%
Price Before
$5.87
Price After
$5.96
Q4 FY2025-8.63%
Report Date
Nov 6, 2025
EPS Beat/Miss
-210.0%
Price Before
$12.52
Price After
$11.44
Q3 FY2025-1.46%
Report Date
Aug 7, 2025
EPS Beat/Miss
-87.5%
Price Before
$13.03
Price After
$12.84
Q2 FY2025-0.14%
Report Date
May 8, 2025
EPS Beat/Miss
-1446.7%
Price Before
$13.83
Price After
$13.81
Q1 FY2025+14.78%
Report Date
Feb 27, 2025
EPS Beat/Miss
-794.4%
Price Before
$9.47
Price After
$10.87
Q4 FY2024+17.24%
Report Date
Nov 7, 2024
EPS Beat/Miss
+55.2%
Price Before
$5.86
Price After
$6.87
Q3 FY2024-9.93%
Report Date
Aug 8, 2024
EPS Beat/Miss
-82.8%
Price Before
$4.43
Price After
$3.99
Avg Beat Reaction+12.54%
Avg Miss Reaction-0.64%
Beat Rate2 / 8 quarters
Largest Move+17.24% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: LNSR ends December
LENSAR, Inc. (LNSR) most recently reported earnings on May 8, 2026 for Q2 FY2026, posting EPS of $1.56 — beating the analyst consensus of $0.18 by +743.2%. The next LNSR earnings date is expected around September 1, 2026.
Each quarter, investors track LNSR earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. LNSR revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
LNSR's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
LNSR earnings · 5 questionsLENSAR, Inc.'s next earnings report is expected around September 1, 2026. LNSR typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; LNSR historically reports after market close (AMC).
LNSR earnings datewhen is LNSR earningsLNSR next earnings datewhen does LNSR report earningsLNSR earnings calendar
▸ Source: FMP · LENSAR, Inc. SEC filings · US GAAP · LENSAR, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026